Fusion Pharma Closes $212.5 million initial public offering with support from CFGI
CFGI’s Capital Markets team announced that it assisted Fusion Pharmaceuticals (NASDAQ: FUSN) with an initial public offering of 12,500,000 common shares at $17 per share for gross proceeds of $212.